Avantor, Inc. (AVTR)
14.81
-0.07
(-0.47%)
USD |
NYSE |
Sep 11, 16:00
14.80
0.00 (0.00%)
Pre-Market: 20:00
Avantor Market Cap : 10.02B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 10.02B |
| September 10, 2026 | 10.07B |
| September 09, 2026 | 10.07B |
| September 08, 2026 | 10.32B |
| September 04, 2026 | 10.13B |
| September 03, 2026 | 10.28B |
| September 02, 2026 | 9.911B |
| September 01, 2026 | 9.606B |
| August 31, 2026 | 9.836B |
| August 28, 2026 | 9.863B |
| August 27, 2026 | 9.884B |
| August 26, 2026 | 9.809B |
| August 25, 2026 | 9.755B |
| August 24, 2026 | 9.647B |
| August 21, 2026 | 9.782B |
| August 20, 2026 | 9.640B |
| August 19, 2026 | 9.444B |
| August 18, 2026 | 9.018B |
| August 17, 2026 | 9.133B |
| August 14, 2026 | 9.241B |
| August 13, 2026 | 9.370B |
| August 12, 2026 | 9.424B |
| August 11, 2026 | 9.315B |
| August 10, 2026 | 9.288B |
| August 07, 2026 | 9.194B |
| Date | Value |
|---|---|
| August 06, 2026 | 8.916B |
| August 05, 2026 | 9.038B |
| August 04, 2026 | 9.255B |
| August 03, 2026 | 9.248B |
| July 31, 2026 | 9.322B |
| July 30, 2026 | 9.376B |
| July 29, 2026 | 9.728B |
| July 28, 2026 | 8.402B |
| July 27, 2026 | 7.956B |
| July 24, 2026 | 7.739B |
| July 23, 2026 | 7.751B |
| July 22, 2026 | 7.478B |
| July 21, 2026 | 7.505B |
| July 20, 2026 | 7.280B |
| July 17, 2026 | 7.560B |
| July 16, 2026 | 7.689B |
| July 15, 2026 | 7.648B |
| July 14, 2026 | 7.710B |
| July 13, 2026 | 7.211B |
| July 10, 2026 | 7.095B |
| July 09, 2026 | 7.177B |
| July 08, 2026 | 6.665B |
| July 07, 2026 | 6.966B |
| July 06, 2026 | 7.082B |
| July 02, 2026 | 7.048B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Medpace Holdings, Inc. | 16.36B |
| Champions Oncology, Inc. | 70.82M |
| Personalis, Inc. | 1.724B |
| Adaptive Biotechnologies Corp. | 3.849B |
| 10X Genomics, Inc. | 8.936B |
Market Cap Related Metrics
| PS Ratio | 1.532 |
| Price to Book Value | 1.780 |
| Price to Free Cash Flow | 22.11 |
| Price | 14.81 |
| Earnings Yield | -5.72% |
| Operating PE Ratio | 18.68 |
| Normalized PE Ratio | 1763.10 |